Skip to main content

H.R. 6946

Referred to Committee

SAFE Act of 2022

Introduced 3/7/2022•117th Congress•House

Latest Action

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

11/1/2022 • House

Summary

Save Americans from the Fentanyl Emergency Act of 2022 or the SAFE Act of 2022

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.

The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

Introduced in House • 3/7/2022

Enter your district to see how this bill affects your community
-

Topics & Subjects

Administrative law and regulatory proceduresCongressional oversightCriminal procedure and sentencingDepartment of JusticeDrug trafficking and controlled substancesGovernment studies and investigationsInternational law and treatiesLicensing and registrationsManufacturingResearch administration and funding

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (11)

Party Breakdown

6
Democrats
5
Republicans
0
Independents

Sponsor

R[
Rep. Pappas, Chris [D-NH-1]

Democrat • NH-1

Sponsored 3/7/2022

Cosponsors (10)

R[
Rep. Newhouse, Dan [R-WA-4]

R-WA-4

Joined 3/7/2022

R[
Rep. Budd, Ted [R-NC-13]

R-NC-13

Joined 3/7/2022

R[
Rep. Suozzi, Thomas R. [D-NY-3]

D-NY-3

Joined 3/8/2022

R[
R[
Rep. Cuellar, Henry [D-TX-28]

D-TX-28

Joined 3/8/2022

Bill Journey

Originated in the House

Introduced

March 7, 2022

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House3/7/2022

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors10